tykhr
sign in
free sign up
Kalaris Therapeutics, Inc.
Biotechnology
Healthcare
KLRS
18.70 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.43
52 week high
23.23
high
4.82
52 week low
0.00
low
4.40
growth
-72.93 %
previous Close
4.40
P/E ratio
-2
market cap
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
-10.20 M
0.00 %
eps
-2.52 %
30.75 %
eps surprise
-227.27 %
net profit margin
-1019600000.00 %
0.00 %
operating incoming
-10.35 M
0.00 %
net change in cash
99.83 M
0.00 %
cash on hand
101 M
0.00 %
cost of revenue
0.00 %
top